Newal R&D
The Newal R&D Team
Dr Rupert Holms
Chief Executive Officer
London
Dr John Abeles
Chairman
New York
Dr Rupert Holms, CEO of NewalR&D, is the inventor and world-expert on ezrin peptide technology. Dr Holms is the founder & former executive chairman of the profitable, 120 million Euro turnover (in roubles), Nearmedic Group in Moscow, that employs over one thousand people and brought four immune pharmaceutical products to market, together with a range of STI diagnostic products. Dr Holms is also the founder & former CEO of hVIVO PLC, the London-based antiviral drug screening company.
Dr John Abeles, Chairman of NewalR&D, is a veteran biotech founder & financier based in New York and Florida. Dr. Abeles is the Founder & General Partner of Northlea Partners LLLP, a venture and private capital partnership based in Boca Raton, Florida, USA. Dr Abeles has been instrumental in founding many early stage medical and biotech companies in the USA; some became Public Companies, others were acquired by major corporations.
Dr Rupert Holms, CEO of NewalR&D, and Dr Abeles, Chairman of NewalR&D, have been friends and colleagues since 1985. NewalR&D is currently seeking additional executives in all relevant fields to assist in the development of NewalR&D.